Back to Search
Start Over
LncRNA HULC augments high glucose-associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy.
- Source :
-
Biology of the cell [Biol Cell] 2024 Sep; Vol. 116 (9), pp. e2400034. Date of Electronic Publication: 2024 Jul 01. - Publication Year :
- 2024
-
Abstract
- Background Information: One of the confounding factors in pancreatic cancer (PC) pathogenesis is hyperglycemia. The molecular mechanism by which high glucose (HG) influences PC severity is poorly understood. Our investigation delved into the impact of lncRNA highly upregulated in liver cancer (HULC) and its interaction with yes-associated protein (YAP) in regulating the fate of pancreatic ductal adenocarcinoma cells (PDAC) under HG-induced conditions. PDAC cells were cultured under normal or HG conditions. We thereafter measured the effect of HG on the viability of PDAC cells, their migration potential and drug resistance properties. The lncRNAs putatively dysregulated in PC and diabetes were shortlisted by bioinformatics analysis followed by wet lab validation of function.<br />Results: HG led to enhanced proliferation and drug refractoriness in PDAC cells. HULC was identified as one of the major deregulated lncRNAs following bioinformatics analysis. HULC was found to regulate the expression of the potent transcriptional regulator - YAP through selective histone modifications at the YAP promoter. siRNA-mediated ablation of HULC resulted in a concurrent decrease in YAP transcriptional activity. Importantly, HULC and YAP were found to co-operatively regulate the cellular homeostatic process autophagy, thus inculcating drug resistance and proliferative potential in PDAC cells. Moreover, inhibition of autophagy or YAP led to a decrease in HULC levels, suggesting the existence of an inter-regulatory feedback loop.<br />Conclusions: We observed that HG triggers aggressive properties in PDAC cells. Mechanistically, up-regulation of lncRNA HULC resulted in activation of YAP and differential regulation of autophagy coupled to increased proliferation of PDAC cells.<br />Significance: Inhibition of HULC and YAP may represent a novel therapeutic strategy for PDAC. Furthermore, this study portrays the intricate molecular interplay between HULC, YAP and autophagy in PDAC pathogenesis.<br /> (© 2024 The Author(s). Biology of the Cell published by Wiley‐VCH GmbH on behalf of Société Française des Microscopies and Société Biologie Cellulaire de France.)
- Subjects :
- Humans
Adaptor Proteins, Signal Transducing metabolism
Adaptor Proteins, Signal Transducing genetics
Carcinoma, Pancreatic Ductal genetics
Carcinoma, Pancreatic Ductal metabolism
Carcinoma, Pancreatic Ductal pathology
Cell Line, Tumor
Cell Movement
Cell Proliferation
Disease Progression
Gene Expression Regulation, Neoplastic
Glucose metabolism
Glucose pharmacology
Autophagy drug effects
Drug Resistance, Neoplasm
Pancreatic Neoplasms genetics
Pancreatic Neoplasms pathology
Pancreatic Neoplasms metabolism
RNA, Long Noncoding genetics
RNA, Long Noncoding metabolism
Transcription Factors metabolism
Transcription Factors genetics
YAP-Signaling Proteins metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1768-322X
- Volume :
- 116
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Biology of the cell
- Publication Type :
- Academic Journal
- Accession number :
- 38949568
- Full Text :
- https://doi.org/10.1111/boc.202400034